June 11, 2025

8-Week Oral Therapy Approved for Acute HCV

The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention.

Conexiant

June 09, 2025

Appendix Tumors Climb for Millennials, Gen Z

Younger generations—particularly individuals born after 1980—face higher rates of appendiceal cancer, with incidence increasing more than fourfold in recent decades, according to a new study.

Conexiant

June 09, 2025

Steroid Use Quietly Weakens Skin's Elasticity: Study

Long-term steroid use can damage skin by silently disrupting elastic fibers before visible thinning appears, new research shows.

Conexiant

June 03, 2025

Study Links Nodules to Diabetic Nerve Damage

Researchers studying human spinal ganglia uncovered that 1 in 4 neurons are lost in diabetic nerve damage, marked by the formation of glial cell clusters called Nageotte nodules.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 27, 2025

Mucous Membrane Pemphigoid Linked to Higher Skin Cancer Risk

Investigators found that patients with mucous membrane pemphigoid, especially those with severe disease, face increased risks of squamous and basal cell carcinomas.

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

Longer Fixation Reduces Artifacts in Testicular Tumors

Longer formalin fixation reduced tumor displacement artifacts in testicular germ cell tumors, helping pathologists distinguish true from pseudo–lymphovascular invasion, especially in larger seminomas.

Conexiant

May 22, 2025

At-Home HPV Test Matches Clinic Accuracy

Researchers found that an at-home self-collection device for HPV testing demonstrated high accuracy and safety, matching clinician-collected results for cervical cancer screening.

Conexiant